Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Guerbet SA

Latest From Guerbet SA

GBCA Sponsors Must Conduct Human, Animal Studies To Assess Safety

US FDA is requiring additional safety measures related to GBCAs, but holds that there is no direct relationship established between gadolinium retention and kidney function.

Post Market Regulation & Studies Safety

Warning Label For Gadolinium Contrast Agents Gets US FDA Panel Backing

Advisory committee agrees that risks of gadolinium retention in the brain and other organs need further study; actor Chuck Norris' wife was among several patients who testified of devastating medical problems following administration of agents.

BioPharmaceutical Advisory Committees

Gadolinium Contrast Agent Retention In Brain May Require Label Warning

US FDA advisory committee to consider whether regulatory actions such as a labeling change are needed and what studies could be done to investigate potential adverse events associated with gadolinium retention in the brain and other body organs.

Advisory Committees FDA

Guerbet Names New Chief Digital Officer To Lead Innovation

Medical imaging specialist Guerbet has appointed a new chief digital officer to oversee the company's innovation strategy.

Appointments Digital Health
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Guerbet SA
  • Senior Management
  • Yves L'Epine, CEO
    Jean-Francois Le Martret, CFO
  • Contact Info
  • Guerbet SA
    Phone: (33) 1 45 91 50 00
    Rue des Vanesses, 15
    P.O. Box 50400 Villepinte, 93420